Cardiac allograft vasculopathy in heart transplanted recipients: The multivessel study

Niels Møller Jensen1,2, Tor Skibsted Clemmensen1, Kamilla Pernille Bjerre1,2

  • 1Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

JHLT Open
|March 27, 2025
PubMed

Insights

Cardiac allograft vasculopathy (CAV) unequally affects coronary arteries after heart transplant. The left descending artery shows the most significant changes and best predicts CAV progression using optical coherence tomography (OCT).

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Medical Imaging

Background:

  • Cardiac allograft vasculopathy (CAV) is a common complication after heart transplantation.
  • Understanding CAV's impact on different coronary arteries is crucial for patient outcomes.

Purpose of the Study:

  • To assess if CAV causes differential vascular remodeling in major coronary arteries using quantitative optical coherence tomography (OCT).
  • To explore the prognostic value of OCT-derived measurements from individual coronary arteries for CAV progression.

Main Methods:

  • Sixty-four heart transplant recipients underwent 3-vessel OCT and coronary angiography.
  • OCT data were categorized by CAV severity (none, mild, moderate, severe).
  • Disease progression was tracked until July 2022.

Main Results:

  • Significant differences in lumen/intima and intima/media ratios were observed in severe CAV across coronary arteries.
  • The left descending artery (LAD) exhibited smaller lumen and larger intima areas compared to other arteries in CAV groups.
  • LAD-derived intima/media and lumen/intima ratios were the strongest predictors of CAV progression, outperforming predictions from all three arteries.

Conclusions:

  • CAV differentially impacts vascular remodeling in major coronary arteries, with the LAD being most affected.
  • OCT measurements from the LAD provide superior prognostic information for CAV progression compared to other coronary arteries.
Abstract

Related Concept Videos